|
Schizophrenia
Citations 61-70 of 318 total displayed.
|
Past content
(since Jan 1998):
|
- Letters to the Editor
Gene–Brain Structure Relationships: Arbitrary Assumptions of Heterogeneity Generate Unfalsifiable Claims—Reply
- Hugh M. D. Gurling; Hugo Critchley; Susmita R. Datta; Andrew McQuillin; Ekaterina Blaveri; Srinivasa Thirumalai; Jonathan Pimm; Robert Krasucki; Gursharan Kalsi; Digby Quested; Jacob Lawrence; Nicholas Bass; Khalid Choudhury; Vinay Puri; Owen ODaly; David Curtis; Douglas Blackwood; Walter Muir; Anil K. Malhotra; Robert W. Buchanan; Catriona D. Good; Richard S. J. Frackowiak; Raymond J. Dolan
Arch Gen Psychiatry 2007; 64: 1098-1099.
[Extract]
[Full text]
[PDF]
- Original Articles
Incidence of Schizophrenia in a Nationwide Cohort of Patients With Type 1 Diabetes Mellitus
- Hannu Juvonen; Antti Reunanen; Jari Haukka; Maria Muhonen; Jaana Suvisaari; Ritva Arajärvi; Timo Partonen; Jouko Lönnqvist
Arch Gen Psychiatry 2007; 64: 894-899.
[Abstract]
[Full text]
[PDF]
- Letters to the Editor
First- and Second-Generation Antipsychotics: Learning From CUtLASS and CATIE
- Rajiv Tandon; William T. Carpenter; John M. Davis
Arch Gen Psychiatry 2007; 64: 977-978.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
First- vs Second-Generation Antipsychotic Drugs in Schizophrenia
- Chittaranjan Andrade; Saifuddin Kharawala
Arch Gen Psychiatry 2007; 64: 978-a-979-a.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
CUtLASS Confirms CATIE
- Jim Mintz; Alex Kopelowicz
Arch Gen Psychiatry 2007; 64: 978.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
First- vs Second-Generation Antipsychotic Drugs in Schizophrenia—Reply
- Peter B. Jones; Thomas R. E. Barnes; Peter Elton; Linda Davies; Graham Dunn; Helen Lloyd; Karen P. Hayhurst; Robin M. Murray; Alison Marwick; Shôn Lewis
Arch Gen Psychiatry 2007; 64: 979-980.
[Extract]
[Full text]
[PDF]
- Letters to the Editor
Elevated Prenatal Homocysteine Levels and the Risk of Schizophrenia
- Stefan Bleich; Helge Frieling; Thomas Hillemacher
Arch Gen Psychiatry 2007; 64: 980-981.
[Extract]
[Full text]
[PDF]
- Original Articles
Cortical Brain Development in Nonpsychotic Siblings of Patients With Childhood-Onset Schizophrenia
- Nitin Gogtay; Deanna Greenstein; Marge Lenane; Liv Clasen; Wendy Sharp; Pete Gochman; Philip Butler; Alan Evans; Judith Rapoport
Arch Gen Psychiatry 2007; 64: 772-780.
[Abstract]
[Full text]
[PDF]
- Commentaries
Cognitive Improvement in Response to Antipsychotic Drugs: Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
- R. Walter Heinrichs
Arch Gen Psychiatry 2007; 64: 631-632.
[Extract]
[Full text]
[PDF]
- Original Articles
Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial
- Richard S. E. Keefe; Robert M. Bilder; Sonia M. Davis; Philip D. Harvey; Barton W. Palmer; James M. Gold; Herbert Y. Meltzer; Michael F. Green; George Capuano; T. Scott Stroup; Joseph P. McEvoy; Marvin S. Swartz; Robert A. Rosenheck; Diana O. Perkins; Clarence E. Davis; John K. Hsiao; Jeffrey A. Lieberman; for the CATIE Investigators and the Neurocognitive Working Group
Arch Gen Psychiatry 2007; 64: 633-647.
[Abstract]
[Full text]
[PDF]
|
|